Search Site

Andrea Califano, Dr

Academic Appointments

  • Clyde '56 and Helen Wu Professor of Chemical Biology (in Systems Biology) and Professor of Biomedical Informatics and of Biochemistry and Molecular Biophysics (in the Institute for Cancer Genetics)
  • Professor of Biochemistry and Molecular Biophysics

Current Administrative Positions

  • Chair, Department of Systems Biology
  • Director, JP Sulzberger Columbia Genome Center
  • Associate Director, Herbert Irving Comprehensive Cancer Center
Andrea Califano, Dr

Departmental Appointments

  • Department of Systems Biology (Columbia University)
  • Department of Biochemistry and Molecular Biophysics
  • Department of Biomedical Informatics

Languages Spoken

  • French
  • Italian

Centers/Institutes/Programs

  • Herbert Irving Comprehensive Cancer Center

This provider does not accept new patients

Lab Locations

  • Irving Cancer Research Center

    1130 Street Nicholas Avenue
    Room 911/912
    New York, NY 10032
    Phone:
    (212) 851-5183

NIH Grants

  • SYSTEMATIC IDENTIFICATION AND PHARMACOLOGICAL TARGETING OF TUMOR DEPENDENCIES FOR PRECISION CANCER MEDICINE (Federal Gov)

    Jul 1 2017 - Jul 31 2022

    ELUCIDATING THE DEPENDENCIES OF TUMOR INITIATING AND DRUG-RESISTANT NICHES IN HUMAN MALIGNANCIES BY GENOME-WIDE MOLECULAR PROFILING OF SINGLE CELLS (Federal Gov)

    Aug 14 2015 - Jul 31 2022

    CENTERS FOR CANCER SYSTEMS THERAPEUTICS (CAST) (Federal Gov)

    Aug 8 2016 - Jul 31 2021

    DEFINING THE ROLE OF ERG IN MODULATING THE AR CISTROME AND ANTIANDROGEN SENSITIVITY (Federal Gov)

    Apr 1 2015 - Mar 31 2020

    DEFINING THE ROLE OF ERG IN MODULATING THE AR CISTROME AND ANTIANDROGEN SENSITIVITY (Federal Gov)

    Apr 1 2015 - Mar 31 2020

    CANCER CENTER SUPPORT GRANT (Federal Gov)

    Jul 1 2014 - Jun 30 2019

    GENE NETWORK PERTURBATIONS IN ALCOHOL DEPENDENCE - A SYSTEMS BIOLOGY APPROACH (Federal Gov)

    Sep 5 2013 - Aug 31 2018

    SYSTEMS BIOLOGY OF TUMOR PROGRESSION AND DRUG RESISTANCE (Federal Gov)

    Jun 1 2012 - Apr 30 2018

    GENE NETWORK PERTURBATIONS IN ALCOHOL DEPENDENCE - A SYSTEMS BIOLOGY APPROACH (Federal Gov)

    Sep 5 2013 - Aug 31 2017

    GENE NETWORK PERTURBATIONS IN ALCOHOL DEPENDENCE - A SYSTEMS BIOLOGY APPROACH (Federal Gov)

    Sep 5 2013 - Aug 31 2017

    STORAGE SYSTEM FOR HIGH PERFORMANCE COMPUTING (Federal Gov)

    Mar 15 2016 - Mar 14 2017

    EX VIVO COMPOUND PRIORITIZATION FOR GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (Private)

    Jul 1 2015 - Dec 31 2016

    ASSESSING SYNERGISTIC COMPOUND ACTIVITY IN GLIOBLASTOMA (Federal Gov)

    Sep 24 2015 - Oct 31 2016

    INVESTIGATION OF CYSVIEW CYTOTOXICITY FOR HUMAN BLADDER ORGANOIDS (Private)

    Aug 1 2015 - Jul 31 2016

    NATIONAL CENTER: MULTISCALE ANALYSIS OF GENOMIC AND CELLULAR NETWORKS (MAGNET) (Federal Gov)

    Sep 26 2005 - Jul 31 2016

    MERRIMACK PHARMACEUTICAL RNA-SEQ PROJECT (Private)

    Jul 21 2014 - Jul 20 2016

    CLINICAL AND TRANSLATIONAL SCIENCE AWARD (UL1) (Federal Gov)

    Sep 30 2006 - Jun 30 2016

    A SYSTEMS BIOLOGY APPROACH TO IDENTIFY AND EVALUATE NOVEL DRUG TARGET FOR AGGRESSIVE PROSTATE CANCER (Private)

    May 20 2013 - May 20 2016

    INTEGRATIVE ANALYSIS GENOMIC AND PROTEOMIC DATA FROM THE CANCER GENOME ATLAS (Federal Gov)

    Feb 1 2015 - Jan 31 2016

    COMPUTATIONAL ANALYSIS OF HIGH-GRADE GLIOMAS (Federal Gov)

    Sep 1 2009 - Aug 31 2015

    MOLECULAR PATHOGENESIS OF BASAL-LIKE BREAST CANCER (Federal Gov)

    Jul 1 2002 - Aug 31 2015

    ELUCIDATION OF CANCER PATHWAYS AND DRUGGABLE TARGETS USING MOUSE MODELS (Federal Gov)

    Sep 30 1999 - Jul 31 2015

    DISCOVERY OF AKT-REGULATED TRANSCRIPTIONAL MODULES ASSOCIATED WITH MALIGNANT PHENOTYPES IN BREAST CANCER (Federal Gov)

    Mar 1 2012 - Feb 28 2015

    DISSECTING THE MOLECULAR MECHANISM REGULATING SOMATIC CELL REPROGRAMMING (Private)

    Oct 1 2010 - Sep 30 2014

    GENE NETWORK PERTURBATIONS IN ALCOHOL DEPENDENCE - A SYSTEMS BIOLOGY APPROACH (Federal Gov)

    Sep 5 2013 - Aug 31 2014

    PROFILING SIGNATURES OF SYNERGISTIC CHEMICAL PERTURBATIONS IN DIVERSE CELLULAR C (Federal Gov)

    Sep 16 2011 - Aug 31 2014

    A SYSTEMS APPROACH TO ELUCIDATE MECHANISMS OF DRUG ACTIVITY AND SENSITIVITY USING LINCS DATA (Federal Gov)

    Sep 24 2011 - Jun 30 2014

    DATA COORDINATION CENTER FOR SERIOUS ADVERSE EVENT CONSORTIUM (Private)

    Jul 1 2010 - Mar 30 2014

    P2ALS INITIATIVE (Private)

    Jan 1 2011 - Dec 31 2013

    SAIC FREDERICK (Federal Gov)

    Sep 1 2012 - Sep 30 2013

    ELUCIDATING THE MECHANISMS OF NEUROENDOCRINE TUMOR INITIATION & PROGRESSION (Private)

    Oct 1 2011 - Sep 30 2013

    SUBPROJECT FOR INSTITUTION # 08-8993 (Private)

    Oct 1 2008 - Sep 30 2013

    HIGH-PERFORMANCE COMPUTE CLUSTER FOR BIOMEDICAL COMPUTING (Federal Gov)

    Aug 1 2012 - Jul 31 2013

    2009 CABIG IN SILICO RESEARCH CENTERS OF EXCELLENCE (Federal Gov)

    Sep 15 2009 - Sep 14 2012

    SYSTEMS BIOLOGY OF TUMOR PROGRESSION AND DRUG-RESISTANCE (Federal Gov)

    Sep 30 2009 - Aug 31 2012

    CABIG KNOWLEDGE CENTER FOR MOLECULAR ANALYSIS TOOLS (GEWORKBENCH, GENEPATTERN, CAINTEGRATOR) (Federal Gov)

    Jun 2 2008 - Jun 1 2012

    COLLABORATIVE STUDY ON THE SYSTEMS BIOLOGY OF VULNERABILITY TO STRESS (Federal Gov)

    Aug 1 2008 - May 31 2012

    PATHWAY COMMONS: RESEARCH RESOURCE FOR BIOLOGICAL PATHWAYS (Federal Gov)

    Jan 4 2008 - Dec 31 2011

    INTEGRATION OF MOUSE MODELS INTO HUMAN CANCER RESEARCH (Federal Gov)

    Oct 5 2009 - Sep 30 2011

    INTEGRATION OF MOUSE MODELS INTO HUMAN CANCER RESEARCH (Federal Gov)

    Oct 5 2009 - Sep 30 2011

    GENETIC NETWORK INFERENCE WITH COMBINATIONAL PHENOTYPES (Federal Gov)

    Jun 21 2005 - Apr 30 2011

    INTEGRATIVE CANCER RESEARCH (ICR WORKSPACE DEVELOPER CABIG (Federal Gov)

    Mar 7 2008 - Apr 14 2011

    REGULATORY MODULES IN NORMAL AND TRANFORMED B-CELLS (Federal Gov)

    Jul 1 2005 - Mar 31 2011

    COMPUTATIONAL AND EXPERIMENTAL METHODS TO ELUCIDATE GENETIC REGULATORY MECHANISMS IN NORMAL AND MALIGNANT MAMMALIAN... (Private)

    Sep 1 2006 - Aug 31 2008

    ACADEMIC MEDICINE DEVELOPMENT COMPANY (Private)

    Dec 1 2001 - Jun 30 2005